knowledge -WSS

knowledge

author：leisure time 2025-09-06 02:05:56 - browse：644

Is biotech back from its downturn? Can Nvidia solve biology? And is it wise to do a deal on a party bus?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Recording from the J.P. Morgan Healthcare Conference, we discuss how a spate of deals and some intermittent sunshine seem to have brightened the outlook for biotech at the outset of 2024. We also talk about the latest twist in the Sarepta Therapeutics saga, a ubiquitous dealmaker, and life on the party circuit.

For more on what we cover, here’s the news on Sarepta; here’s more on Nvidia; here’s the story on Centerview; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： Roche subsidiary Foundation Medicine opens new headquarters

entertainment

WSS

Washington mulls new rules to avert another Change Healthcare

Abortion pill Supreme Court ruling could impact entire drug industry

Primary care physicians play key roles in Alzheimer's management

The Readout: Lenmeldy, GLP

Steward Health Care has deal to sell doctor network to UnitedHealth

States should stop sabotaging methadone treatment reform

focus

knowledge

hotspot

Medicare details structure of new drug price negotiation program

Why the world’s most expensive drug might be worth the price

The cancer drug shortage isn’t new — and neither are the solutions

FDA's naming rule on biosimilars has undermined competition

Hollywood unions extend contract negotiations for actors

Readout Newsletter: Cardior, Regeneron, Nuvation, Dyne and more

Continuity nursing helped my family in our darkest PICU moments

Readout Newsletter: Merck, Vertex, and Viking updates

Dobbs anniversary: the lost opportunity of abortion as health care

Readout Newsletter: Blackstone Life Sciences, Merck, Bluebird Bio

focus

Covid vaccine financial winners and losers, from Pfizer to Novavax

Readout LOUD podcast: mifepristone case, GLP

There's no autism epidemic. It's an autism diagnosis epidemic

Abortion pill case raises question: who can sue the FDA?

Roche subsidiary Foundation Medicine opens new headquarters

Donor acceptance rates hint at racial, gender bias in heart transplants: study

hotspot

entertainment

Wikipedia

Wikipedia